Benzinga's Top Pre-Market Gainers
Discovery Laboratories Inc (NASDAQ: DSCO) shares gained 40.27% to $5.26 in pre-market trading. DSCO reported that the Food and Drug Administration (FDA) approved its respiratory distress syndrome treatment Surfaxin.
Ciena Corp (NASDAQ: CIEN) soared 8.33% to $14.56 in the pre-market trading. Ciena reported a narrower first-quarter loss.
TriQuint Semiconductor Inc (NASDAQ: TQNT) added 4.62% to $6 in the pre-market session. TQNT shares have dropped 55.02% over the past 52 weeks, while the S&P 500 index has gained 1.77% in the same period.
Netflix Inc (NASDAQ: NFLX) surged 4.55% to $112 in the pre-market session. NFLX' trailing-twelve-month ROE is 48.47%.
MAKO Surgical Corp (NASDAQ: MAKO) moved up 4.02% to $38.85 in the pre-market session. MAKO reported a strong rise in its Q4 revenue.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.